Hepatitis Monthly

Published by: Kowsar

Liver Mitochondrial DNA Copy Number and Deletion Levels May Contribute to Nonalcoholic Fatty Liver Disease Susceptibility

Sharareh Kamfar 1 , 2 , Seyed Moayed Alavian 3 , 4 , Massoud Houshmand 5 , Reza Yadegarazari 6 , Bahram Seifi Zarei 7 , Alireza Khalaj 8 , Noshin Shabab 2 and Massoud Saidijam 1 , 2 , *
Authors Information
1 Department of Molecular Medicine and Genetics, School of Medicine, Hamadan University of Medical Sciences, Hamadan, IR Iran
2 Research Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, IR Iran
3 Baqiyatallah Research Center for Gastroenterology and Liver Diseases (BRCGL), Baqiyatallah University of Medical Sciences, Tehran, IR Iran
4 Middle East Liver Diseases (MELD) Center, Tehran, IR Iran
5 Department of Medical Genetics, National Institute for Genetic Engineering and Biotechnology, Tehran, IR Iran
6 Shohada Hospital of Harsin, Kermanshah University of Medical Sciences, Kermanshah, IR Iran
7 School of Medicine, Shahid Beheshti Hospital, Hamadan University of Medical Sciences, Hamadan, IR Iran
8 Obesity Treatment Center, Department of Surgery, Shahed University, Tehran, IR Iran
Article information
  • Hepatitis Monthly: December 01, 2016, 16 (12); e40774
  • Published Online: November 9, 2016
  • Article Type: Research Article
  • Received: July 14, 2016
  • Revised: September 23, 2016
  • Accepted: November 5, 2016
  • DOI: 10.5812/hepatmon.40774

To Cite: Kamfar S, Alavian S M, Houshmand M, Yadegarazari R, Seifi Zarei B, et al. Liver Mitochondrial DNA Copy Number and Deletion Levels May Contribute to Nonalcoholic Fatty Liver Disease Susceptibility, Hepat Mon. 2016 ; 16(12):e40774. doi: 10.5812/hepatmon.40774.

Copyright © 2016, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Gusdon AM, Song KX, Qu S. Nonalcoholic Fatty liver disease: pathogenesis and therapeutics from a mitochondria-centric perspective. Oxid Med Cell Longev. 2014; 2014: 637027[DOI][PubMed]
  • 2. Williams KH, Shackel NA, Gorrell MD, McLennan SV, Twigg SM. Diabetes and nonalcoholic Fatty liver disease: a pathogenic duo. Endocr Rev. 2013; 34(1): 84-129[DOI][PubMed]
  • 3. Weiss J, Rau M, Geier A. Non-alcoholic fatty liver disease: epidemiology, clinical course, investigation, and treatment. Dtsch Arztebl Int. 2014; 111(26): 447-52[DOI][PubMed]
  • 4. Pereira K, Salsamendi J, Casillas J. The Global Nonalcoholic Fatty Liver Disease Epidemic: What a Radiologist Needs to Know. J Clin Imaging Sci. 2015; 5: 32[DOI][PubMed]
  • 5. Bhatt HB, Smith RJ. Fatty liver disease in diabetes mellitus. Hepatobiliary Surg Nutr. 2015; 4(2): 101-8[DOI][PubMed]
  • 6. Masuoka HC, Chalasani N. Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals. Ann N Y Acad Sci. 2013; 1281: 106-22[DOI][PubMed]
  • 7. Garcia-Ruiz C, Baulies A, Mari M, Garcia-Roves PM, Fernandez-Checa JC. Mitochondrial dysfunction in non-alcoholic fatty liver disease and insulin resistance: cause or consequence? Free Radic Res. 2013; 47(11): 854-68[DOI][PubMed]
  • 8. Rolo AP, Teodoro JS, Palmeira CM. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radic Biol Med. 2012; 52(1): 59-69[DOI][PubMed]
  • 9. Grattagliano I, de Bari O, Bernardo TC, Oliveira PJ, Wang DQ, Portincasa P. Role of mitochondria in nonalcoholic fatty liver disease--from origin to propagation. Clin Biochem. 2012; 45(9): 610-8[DOI][PubMed]
  • 10. Begriche K, Massart J, Robin MA, Bonnet F, Fromenty B. Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease. Hepatology. 2013; 58(4): 1497-507[DOI][PubMed]
  • 11. Pessayre D. Role of mitochondria in non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2007; 22 Suppl 1-7[DOI][PubMed]
  • 12. Hernaez R. Genetic factors associated with the presence and progression of nonalcoholic fatty liver disease: a narrative review. Gastroenterol Hepatol. 2012; 35(1): 32-41[DOI][PubMed]
  • 13. Dongiovanni P, Romeo S, Valenti L. Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis. Biomed Res Int. 2015; 2015: 460190[DOI][PubMed]
  • 14. Dongiovanni P, Anstee QM, Valenti L. Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment. Curr Pharm Des. 2013; 19(29): 5219-38[PubMed]
  • 15. Stewart JB, Chinnery PF. The dynamics of mitochondrial DNA heteroplasmy: implications for human health and disease. Nat Rev Genet. 2015; 16(9): 530-42[DOI][PubMed]
  • 16. Zhang Y, Ma Y, Bu D, Liu H, Xia C, Zhang Y, et al. Deletion of a 4977-bp Fragment in the Mitochondrial Genome Is Associated with Mitochondrial Disease Severity. PLoS One. 2015; 10(5)[DOI][PubMed]
  • 17. Dimberg J, Hong TT, Nguyen LT, Skarstedt M, Lofgren S, Matussek A. Common 4977 bp deletion and novel alterations in mitochondrial DNA in Vietnamese patients with breast cancer. Springerplus. 2015; 4: 58[DOI][PubMed]
  • 18. Zhou W, Zhu M, Gui M, Huang L, Long Z, Wang L, et al. Peripheral blood mitochondrial DNA copy number is associated with prostate cancer risk and tumor burden. PLoS One. 2014; 9(10)[DOI][PubMed]
  • 19. Thyagarajan B, Wang R, Nelson H, Barcelo H, Koh WP, Yuan JM. Mitochondrial DNA copy number is associated with breast cancer risk. PLoS One. 2013; 8(6)[DOI][PubMed]
  • 20. Chiappini F, Barrier A, Saffroy R, Domart MC, Dagues N, Azoulay D, et al. Exploration of global gene expression in human liver steatosis by high-density oligonucleotide microarray. Lab Invest. 2006; 86(2): 154-65[DOI][PubMed]
  • 21. Sookoian S, Rosselli MS, Gemma C, Burgueno AL, Fernandez Gianotti T, Castano GO, et al. Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: impact of liver methylation of the peroxisome proliferator-activated receptor gamma coactivator 1alpha promoter. Hepatology. 2010; 52(6): 1992-2000[DOI][PubMed]
  • 22. Pirola CJ, Scian R, Gianotti TF, Dopazo H, Rohr C, Martino JS, et al. Epigenetic Modifications in the Biology of Nonalcoholic Fatty Liver Disease: The Role of DNA Hydroxymethylation and TET Proteins. Medicine (Baltimore). 2015; 94(36)[DOI][PubMed]
  • 23. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012; 55(6): 2005-23[DOI][PubMed]
  • 24. Zabihi Diba L, Mohaddes Ardebili SM, Gharesouran J, Houshmand M. Age-related decrease in mtDNA content as a consequence of mtDNA 4977 bp deletion. Mitochondrial DNA A DNA Mapp Seq Anal. 2016; 27(4): 3008-12[DOI][PubMed]
  • 25. Jiang WW, Masayesva B, Zahurak M, Carvalho AL, Rosenbaum E, Mambo E, et al. Increased mitochondrial DNA content in saliva associated with head and neck cancer. Clin Cancer Res. 2005; 11(7): 2486-91[DOI][PubMed]
  • 26. Lee HC, Yin PH, Lin JC, Wu CC, Chen CY, Wu CW, et al. Mitochondrial genome instability and mtDNA depletion in human cancers. Ann N Y Acad Sci. 2005; 1042: 109-22[DOI][PubMed]
  • 27. Mambo E, Chatterjee A, Xing M, Tallini G, Haugen BR, Yeung SC, et al. Tumor-specific changes in mtDNA content in human cancer. Int J Cancer. 2005; 116(6): 920-4[DOI][PubMed]
  • 28. Wang Y, Liu VW, Xue WC, Cheung AN, Ngan HY. Association of decreased mitochondrial DNA content with ovarian cancer progression. Br J Cancer. 2006; 95(8): 1087-91[DOI][PubMed]
  • 29. Mizumachi T, Muskhelishvili L, Naito A, Furusawa J, Fan CY, Siegel ER, et al. Increased distributional variance of mitochondrial DNA content associated with prostate cancer cells as compared with normal prostate cells. Prostate. 2008; 68(4): 408-17[DOI][PubMed]
  • 30. Liu CS, Tsai CS, Kuo CL, Chen HW, Lii CK, Ma YS, et al. Oxidative stress-related alteration of the copy number of mitochondrial DNA in human leukocytes. Free Radic Res. 2003; 37(12): 1307-17[PubMed]
  • 31. Lee HC, Wei YH. Mitochondrial biogenesis and mitochondrial DNA maintenance of mammalian cells under oxidative stress. Int J Biochem Cell Biol. 2005; 37(4): 822-34[DOI][PubMed]
  • 32. Ashraf NU, Sheikh TA. Endoplasmic reticulum stress and Oxidative stress in the pathogenesis of Non-alcoholic fatty liver disease. Free Radic Res. 2015; 49(12): 1405-18[DOI][PubMed]
  • 33. Del Ben M, Polimeni L, Baratta F, Bartimoccia S, Carnevale R, Loffredo L, et al. Serum Cytokeratin-18 Is Associated with NOX2-Generated Oxidative Stress in Patients with Nonalcoholic Fatty Liver. Int J Hepatol. 2014; 2014: 784985[DOI][PubMed]
  • 34. Del Ben M, Polimeni L, Carnevale R, Bartimoccia S, Nocella C, Baratta F, et al. NOX2-generated oxidative stress is associated with severity of ultrasound liver steatosis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol. 2014; 14: 81[DOI][PubMed]
  • 35. Gu F, Chauhan V, Kaur K, Brown WT, LaFauci G, Wegiel J, et al. Alterations in mitochondrial DNA copy number and the activities of electron transport chain complexes and pyruvate dehydrogenase in the frontal cortex from subjects with autism. Transl Psychiatry. 2013; 3[DOI][PubMed]
  • 36. Larsen NB, Rasmussen M, Rasmussen LJ. Nuclear and mitochondrial DNA repair: similar pathways? Mitochondrion. 2005; 5(2): 89-108[DOI][PubMed]
  • 37. Frahm T, Mohamed SA, Bruse P, Gemund C, Oehmichen M, Meissner C. Lack of age-related increase of mitochondrial DNA amount in brain, skeletal muscle and human heart. Mech Ageing Dev. 2005; 126(11): 1192-200[DOI][PubMed]
  • 38. Hosgood H3, Liu CS, Rothman N, Weinstein SJ, Bonner MR, Shen M, et al. Mitochondrial DNA copy number and lung cancer risk in a prospective cohort study. Carcinogenesis. 2010; 31(5): 847-9[DOI][PubMed]
  • 39. Bonner MR, Shen M, Liu CS, Divita M, He X, Lan Q. Mitochondrial DNA content and lung cancer risk in Xuan Wei, China. Lung Cancer. 2009; 63(3): 331-4[DOI][PubMed]
  • 40. Krishnan KJ, Reeve AK, Samuels DC, Chinnery PF, Blackwood JK, Taylor RW, et al. What causes mitochondrial DNA deletions in human cells? Nat Genet. 2008; 40(3): 275-9[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments